miR-30c-2-3p Regulates METTL14 Expression and Inhibits Cell Migration in Breast Cancer

Area of Science:

• Molecular Biology
• Epigenetics
• Oncology

Background:

• Breast cancer is a major cause of mortality globally.
• Epigenetic modifications, particularly N⁶ methyladenosine (m⁶A) RNA methylation, are implicated in cancer development.
• MicroRNAs and m⁶A regulators, like METTL14, interact to influence oncogenesis.

Purpose of the Study:

• To investigate the regulatory role of miR-30c-2-3p on METTL14 expression.
• To determine the impact of this regulation on global m⁶A levels.
• To assess the effect on breast cancer cell migration.

Main Methods:

• Transfection of breast epithelial (MCF12A) and breast cancer (MCF7) cells with miR-30c-2-3p mimics.
• RT-qPCR and Western blotting to quantify METTL14 mRNA and protein levels.
• Measurement of global m⁶A RNA methylation levels.
• Wound healing assays to evaluate cell migration.

Main Results:

• miR-30c-2-3p overexpression significantly reduced METTL14 mRNA and protein levels in both cell lines.
• Global m⁶A RNA methylation levels decreased following miR-30c-2-3p mimic transfection.
• miR-30c-2-3p significantly inhibited cell migration in MCF7 and MCF12A cells.

Conclusions:

• miR-30c-2-3p negatively regulates METTL14, impacting global m⁶A levels.
• miR-30c-2-3p acts as a tumor suppressor by inhibiting breast cancer cell migration.
• This miR-30c-2-3p/METTL14/m⁶A axis presents a potential therapeutic strategy for breast cancer.